Vimarsana
Biggest News Aggregation in the World

Page 21 - Genetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetics Inc Today - Breaking & Trending Today

Insider Sell: CFO Richard Riggsbee Sells 30,000 Shares of Myriad Genetics Inc - Vimarsana News

Insider Sell: CFO Richard Riggsbee Sells 30,000 Shares of Myriad Genetics Inc

On November 1, 2023, Richard Riggsbee, the Chief Financial Officer (CFO) of Myriad Genetics Inc (NASDAQ:MYGN), sold 30,000 shares of the company.

Source: yahoo.com
Myriad Genetics (NASDAQ:MYGN) Downgraded by StockNews.com - Vimarsana News

Myriad Genetics (NASDAQ:MYGN) Downgraded by StockNews.com

Myriad Genetics (NASDAQ:MYGN – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday. Several other analysts also recently issued reports on MYGN. JPMorgan Chase & Co. decreased their target price on Myriad Genetics from $18.00 to $17.00 and […]

Autoimmune Disease Testing Market Set to Reach US$15.75 Billion by 2033| Future Market Insights,Inc. - Vimarsana News

Autoimmune Disease Testing Market Set to Reach US$15.75 Billion by 2033| Future Market Insights,Inc.

The global market for Autoimmune Disease Testing is expected to grow from US$ 6.07 billion in 2023 to $15.75 billion by 2033. According to FMI, global demand for autoimmune disease testing could grow at a 10% CAGR from 2023 to 2033.The rising incidence of autoimmune disorders, such as rheumatoid arthritis, lupus, an...

Genomics Market Anticipated To Surpass USD 186.7 Billion By - Vimarsana News

Genomics Market Anticipated To Surpass USD 186.7 Billion By

According to marketresearch.biz, advancements in genomic studies, driven by technologies like next-generation sequencing (NGS) and microarrays, are...

Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023 - Vimarsana News

Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023

31.10.2023 - SALT LAKE CITY, Oct. 31, 2023 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will hold its third quarter earnings conference call on Monday, November 6, 2023 at 4:30 p.m. EDT. The ...